Entrada Therapeutics, Inc. · NASDAQ:TRDA

Rocklage Scott M sold 62,811 Entrada Therapeutics, Inc. shares (Form 4)

Traded Aug 6 to Aug 7, 2026 · Filed Aug 10, 2026

From Aug 6 to Aug 7, 2026, Rocklage Scott M (10% owner) sold 62,811 Entrada Therapeutics, Inc. shares at an average US$6.88 for US$432K, leaving 2,783,781 shares. Filed Aug 10, 2026 (Form 4).

Sold
62,811 shares
Price
US$6.88 average (US$6.85 to US$7.00)
Value
US$432K
Holding after
2,783,781 shares
Trading plan
No
Role
10% owner

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Aug 6, 2026Common StockSale10,494US$7.002,836,098Direct
Aug 7, 2026Common StockSale52,317US$6.852,783,781Direct

Source

View original at SEC

Related